FDA Clearance Tracker · P080002-S002
FC2 FEMALE CONDOM
Last checked: Nov 20, 2026Latest source record: Jun 23, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Jun 23, 2017
Approved
Time to decision
479 days
Received Mar 1, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class II
The decision
- FDA number
- P080002-S002
- Device name
- FC2 FEMALE CONDOM
- Applicant
- Clear Future, Inc.
- Applicant location
- New York City, NY
- Received
- Mar 1, 2016
- Decided
- Jun 23, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P080002
Device type
- Device type
- Single-use internal condom (MBU)
- Device class
- Class II
- Regulation
- 21 CFR 884.5340
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
Approval for your proposed change in the formulation of the FC2 Female Condom.
Source documents
Other decisions for Clear Future, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.